Swapnroop Drugs & Pharmaceuticals is a manufacturer and supplier of Tranilast API for pharmaceutical formulation, research, development and regulated pharmaceutical applications. Tranilast is a synthetic anthranilic acid derivative with antiallergic and mast-cell stabilizing properties.
Tranilast is chemically identified as N-(3,4-Dimethoxycinnamoyl)anthranilic Acid, with CAS No. 53902-12-8, molecular formula C18H17NO5 and molecular weight 327.33 g/mol.
Tranilast is a small-molecule pharmaceutical compound that has been used as an antiallergic medicine. It is associated with inhibition of mast-cell mediator release and has also been investigated for effects involving fibrosis, angiogenesis and inflammatory pathways.
As a pharmaceutical API, Tranilast is supplied as a solid crystalline/powdered material and requires controlled identity, assay, moisture, inorganic residue, elemental impurity and related-substance testing.
Tranilast API is relevant to pharmaceutical applications involving:
Swapnroop Drugs & Pharmaceuticals offers Tranilast API manufacturing and supply support for pharmaceutical customers requiring controlled-quality active pharmaceutical ingredients.
As a Tranilast API manufacturer and supplier in India, Swapnroop focuses on consistent material quality, controlled specifications, appropriate pharmaceutical documentation and reliable supply support.
Tranilast should be packed in suitable, tightly closed pharmaceutical-grade containers with appropriate protection from light, moisture and excessive heat.
Recommended storage should follow the approved product specification. Controlled/refrigerated storage may be used where required by the applicable material specification.
Typical pharmaceutical documentation may include:
Swapnroop Drugs & Pharmaceuticals provides pharmaceutical API manufacturing and supply support with emphasis on quality consistency, controlled specifications and professional technical assistance. Customers seeking a Tranilast API manufacturer and supplier in India can obtain Tranilast for applicable pharmaceutical development and manufacturing requirements.
| Parameter | Specification |
|---|---|
| Appearance | white to off-white crystalline powder |
| Identification | IR & HPLC compliant |
| Assay (HPLC) | NLT 98.0% |
| Loss on Drying | NMT 0.30% |
| Residue on Ignition | NMT 0.20% |
| Heavy Metals | NMT 10 ppm |
| Melting Point | 207–210°C |